Warfarin 10 mg
Sponsors
Janssen Research & Development, LLC
Conditions
Crohn DiseaseHealthyUlcerative Colitis
Phase 1
A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy Subjects
CompletedNCT03058419
Start: 2017-03-14End: 2017-05-15Updated: 2017-06-08
A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis
TerminatedNCT03358706
Start: 2018-02-02End: 2021-11-22Updated: 2025-08-21